asdf098

$BMY bouncing off long-term support (4/5)

Long
NYSE:BMY   Bristol-Myers Squibb Company
Conviction: 4/5
might be better to buy when the stock goes over 1998 resistance


General Thesis
  • bouncing off of multi-cycle support (since 1974)
  • Weekly RSI showing sliiight bullish divergence

Growth
  • Margins quite low compared to own history
  • low growth

Value
  • very cheap
    Fundamentals
    low debt/asset ratio and plenty of cash to deal with short term debts

    Potential Risks
  • expensive market...
  • long-term resistance around 76 since 1998

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.